Interim Report 1 January – 31 March 2022
· Strong finish in the quarter despite a challenging start – new customer record and positive trend in April · Continued focus on UK market – Ideal Med appointed UK distributor · Progress on product development initiatives targeting US market ”Despite a challenging start to the quarter, improvements were identified late March and during April, and it will be interesting to see whether we can confirm this trend in the coming weeks and months. We did set a new record for number of customers during the quarter, with good margin, and the normalisation of business volumes, combined with